Glenvale Packaging offers Yener tooling in UK

Published: 31-May-2011
Manufacturing Packaging

Press tools, parts, maintenance kits and storage boxes are all included in the agreement

Glenvale Packaging, based in Wellingborough, Northamptonshire, operates a UK-wide agreement with Yener Kalip to supply the Turkish company’s tablet press tools.

‘We are able to supply a comprehensive range of tooling designs, which can be fitted to the majority of tablet press machines on the market, all of which benefit from the company’s commitment to maintaining high standards of manufacture and consequent long life performance,’ said Garry Coleman, partner at Glenvale Packaging.

The Yener range comprises single-tip and multi-tip tooling options, together with virtually any bespoke configuration – from round to square, and from triple-radius to heart-shaped. Optional tablet embossing – ideal where reference numbers or logos, for example, need to be added – is also available.

‘We are able to supply not just the press tools, but also parts, maintenance kits and storage boxes, all of which are key elements of the Yener product offer,’ Coleman added.

Yener uses a range of steel, applying processes such as heat treatment to reflect the characteristics of the material being compressed and the duty cycle of the machinery to which the tools will be fitted.

The company also places significant emphasis on its coatings technology, such as chromium nitrite, which helps avoid sticking and provides excellent oxidisation resistance and low friction characteristics.

See more

You may also like

Manufacturing

Glenvale Packaging introduces MultiPharma V10 in the UK

Read more
An automatic capsule filling machine that handles potent products

Trending Articles

  1. FDA issues first cGMP warning letter citing AI misuse in pharmaceutical manufacturing A Michigan-based lab has become the subject of the FDA's first dedicated enforcement action on artificial intelligence misuse in drug manufacturing — a landmark event with far-reaching implications for cGMP compliance across the pharmaceutical supply chain
  2. You need to be a subscriber to read this article.
    Click here to find out more.
    Rice-ing to the occasion: how plant-based excipients are gaining ground in pharmaceutical manufacturing As clean-label expectations migrate from health foods into pharmaceutical supply chains, natural ingredient supplier RIBUS says that rice-based excipients are becoming a credible alternative to synthetic standards
  3. Bristol Myers Squibb licenses Lonza ADC linker-payload technology for undisclosed target BMS has secured exclusive access to Lonza’s SYNtecan linker-payload platform, alongside GlycoConnect and HydraSpace technologies, to advance development of an antibody-drug conjugate against an undisclosed target
  4. Lonza delivers strong performance in Q1 2026 in line with expectations and confirms full-year Outlook 2026 Basel, Switzerland, 8 May 2026 – In its qualitative Q1 2026 business update, Lonza1 reported a strong performance across its CDMO business in line with the expected trajectory for Full-Year 2026. As expected, due to a lower prior year base, campaign timing and product releases, and planned site shutdowns, CER sales growth and CORE EBITDA margin will be notably stronger in the first half of 2026 than in the second half
  5. Piramal Pharma Solutions unveils state-of-the-art payload-linker suite at its Riverview, Michigan facility The Riverview facility provides comprehensive services for active pharmaceutical ingredients (APIs) and high potency APIs (HPAPIs), including specialised solutions for payload-linkers. This cutting-edge suite will significantly enhance the company’s ability to support global payload-linker development and manufacturing and help partners bring complex therapies like antibody-drug conjugates (ADCs) and other bioconjugates to market

Upcoming event

Cleanroom Technology Conference UK

20-21 May 2026 | Conference and Exhibition | Birmingham, UK See all

You may also like

Manufacturing

Glenvale Packaging introduces MultiPharma V10 in the UK

An automatic capsule filling machine that handles potent products
Manufacturing

Glenvale Packaging makes inroads into Europe

Successful installation for a specialist manufacturing chemist in Slovenia removes potential bottlenecks between production and filling operations
Manufacturing

Replacing discontinued OEM degasser modules

Biotech Fluidics introduces direct replacement OEM degasser modules based on upgraded vacuum technology to support continued fluidic instrument supply without costly redesigns
Manufacturing

etherna's mRNA and LNP platforms advance Dropshot Therapeutics' renal disease programme to clinical stage

etherna has announced that partner Dropshot Therapeutics has validated its platforms in preclinical renal disease research and will now progress to IND-enabling studies, with etherna providing GMP manufacturing support ahead of planned Phase I clinical trials in 2027
Manufacturing

CARBOGEN AMCIS introduces SPRINT for early-phase development

A new, phase-appropriate approach designed to accelerate early-phase progression while maintaining scientific rigour
Manufacturing

FUJIFILM Cellular Dynamics opens new iPSC manufacturing facility in US

The new site will serve as the company's headquarters and will increase Fujifilm's capacity for induced pluripotent stem cell development and manufacturing, as demand increases with new approach methods in research
You need to be a subscriber to read this article.
Click here to find out more.
Manufacturing

From bespoke to scalable: closing the manufacturing gap in advanced therapeutics

Dr Kevin Robinson (KSR) spoke to Cytiva’s Nicolas Pivet (NP), Vice President of Manufacturing and Digital Solutions, to find out how digitalisation and scalable manufacturing platforms are shaping the next phase of advanced therapeutics
Subscribe now